Curaleaf Hldgs Inc. (CURLF)
Curaleaf to Report Second Quarter 2026 Financial and Operational Results
Curaleaf to Report Second Quarter 2026 Financial and Operational Results
Malattie rare – Dal CHMP parere positivo per trofinetide per il trattamento della sindrome di Rett
Calix, Inc. (CALX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Microsoft Corporation (MSFT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
DAYBU® (Trofinetide) vom CHMP für die Zulassung in der Europäischen Union empfohlen
Nano-X Imaging Ltd. (NNOX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BitGo Holdings, Inc. (BTGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Veritone, Inc. (VERI) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
FS KKR Capital Corp. (FSK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit